Global Harmonization of Stability Testing Regulations

Global Harmonization of Stability Testing Regulations in Pharma

Posted on By

As the pharmaceutical industry becomes increasingly global, the harmonization of regulatory requirements for stability testing is more crucial than ever. Stability testing is a foundational aspect of pharmaceutical product development and regulatory approval, guiding shelf life determination, packaging selection, and storage conditions. However, regional variations in guidelines have historically presented challenges for multinational submissions and consistent product quality.
Click to read the full article.

Global Harmonization of Stability Testing Regulations, Regulatory Guidelines

How to Harmonize Stability Protocols Across Regulatory Agencies

Posted on By

Harmonizing stability protocols ensures consistency across regions and minimizes the risk of non-compliance. Regulatory bodies often require stability data tailored to local environmental conditions, which can vary significantly between ICH Climatic Zones I–IVb. By standardizing protocols, companies reduce redundancy and better manage global product life cycles.
Click to read the full article.

Global Harmonization of Stability Testing Regulations, Regulatory Guidelines

Step-by-Step Guide to Preparing Globally Compliant Stability Dossiers

Posted on By

A stability dossier provides comprehensive data about the product’s shelf life, degradation profile, storage conditions, and packaging integrity. This includes long-term, intermediate, and accelerated study results with appropriate justification of storage conditions based on ICH Climatic Zones (I–IVb).
Click to read the full article.

Global Harmonization of Stability Testing Regulations, Regulatory Guidelines